Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zovaglutide in Adults With Overweight or Obesity
NCT07230119Phase 3Active, not recruiting
- Sponsor
- QL Biopharm
- Start
- Jan 2026
- Primary completion
- May 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of zovaglutide in obesity, sponsored by QL Biopharm. Started Jan 2026; status: active, not recruiting.
02
Drugs
zovaglutide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07230119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07230119.